anti-VEGF mAb (Mitsui)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-VEGF mAb (Mitsui)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody

Mechanisms of ActionVascular endothelial growth factor receptor antagonists

TargetsVascular endothelial growth factor receptor

Therapy Area/IndicationsDiabetic RetinopathyNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMitsui Chemicals

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesMitsui Chemicals

Active IndicationsN/A

Inactive IndicationsDiabetic RetinopathyNeoplasms

ATC CodeN/A